|
市場調查報告書
最佳實務：轉譯研究-朝向產業轉換前進
Best Practices: Translational Research - Positive Steps on the Path to Industry Transformation
|
最佳實務：轉譯研究-朝向產業轉換前進 是由出版商IDC Health Insights在2011年12月所出版的。
這份英文市場調查報告書包含Pages: 24 價格從美金4500起跳。
轉譯研究做為能整個轉變醫療業界生態系統的潛在轉換方式而備受期待。將從學術至醫藥品研發的多樣利害關係人與醫療供應商相連結等，轉譯研究被視為可大幅提高新式治療法的開發效率，並在短期上能大幅改善病患的治療成果。醫療業界的生態系統複雜，思考活用轉譯研究的相關人士，必須先認識多樣的促進因素，與針對成功而所應對應的法規上障礙。
本報告，針對轉譯研究，彙整其概要以及課題，介紹現在所進展的轉譯研究平台以及最佳實務，整理對於關鍵利害關係人的建議等，由下列摘要形式闡述。
IDC Health Insights的見解
關於本調查
概況
- 商業需求
- 發現研究與臨床診療：一時分離的世界
- 歷史性分裂的世界
- 實現初期研究與診所間早期連動的轉譯研究
- 經營的課題
- 關鍵利害關係人觀點的轉譯研究定義
- 學術研究者
- 轉譯研究中心
- 學術醫療中心
- 生物科技企業
- 醫藥品公司
最佳實務
- 做為針對新藥開發的新行動而出現的共同轉譯研究
- 去除合作上的傳統阻礙
- 轉譯研究的早期且順利導入正在進行中
- 傳達現在價值同時更進一步持續
- 初期的創新與所認為的領導才能：連接醫療業界的價值鏈
- 從最初一步一步累積
- HP在轉譯研究的強化上扮演初期的角色
- 不同的設計、相同目標
- 從開始確保關鍵利害關係人的參與
- 朝向能夠正當化科學強化的技術活用
- 致力於早期的價值傳達
- 可擴展構想的確立
- 「殺手級應用」的發現
- 從Ivy-Covered Walls裡伸手
- 新興/商用轉譯研究合作平台
- 主要的商用轉譯研究平台相關考察
- Microsoft SharePoint
- EMC Documentum
- Oracle Health Sciences Translational Research Center
- IDBS Enterprise Translational Medicine Solution
- SCYNEXIS HEOS
將來展望
主要建議
- 應考量行動
- 一般考量事項
- 針對醫藥品以及生物科技企業的行動
- 生命科學以及其他IT廠商的行動
參考資料
圖
- 新興轉譯研究IT基礎建設
- MD Anderson的核心轉譯研究IT基礎建設的行動
- GIGPAD的夥伴醫療架構
- 現在所使用的轉譯研究合作平台
This IDC Health Insights report highlights the emergence of translational research, a potentially transformative approach that is expected to change the greater health industry ecosystem forever. From bringing diverse key stakeholders ranging from academia to pharma R&D to healthcare providers/payers to practicing physicians, translational research promises to both greatly improve the efficiency of developing new therapeutics and improve patient outcomes over the near term. The health industry ecosystem is complex, and participants hoping to exploit translational research must recognize the diverse drivers and regulatory barriers that must be addressed in order to succeed. "The field of translational research awaits the day when it simply becomes research. We're very early in the transformation process but can expect to experience rapid change over the next several years," according to Alan Louie, research director, IDC Health Insights.
Table of Contents
IDC Health Insights Opinion
In This Study
Situation Overview
The Best Practices
Emergence of Collaborative Translational Research as a New Approach to New Drug Development
Breaking Down Traditional Barriers to Collaboration
Early But Steady Adoption of Translational Research Efforts in Progress
Delivering Value Today, with More to Come
Early Innovation and Thought Leadership: Connecting the Health Industry Value Chain
Starting from the Ground Up
HP Taking an Early Role in Empowering Translational Research
Different Designs, Same Goal
Ensure Key Stakeholder Involvement from the Start
Exploiting Technology to Empower Defensible Science
Focus on Delivering Value Early
Establish an Extensible Vision
Finding a "Killer App"
Reaching Out from Behind Ivy-Covered Walls
Emerging/Commercial Translational Research Collaboration Platforms
Future Outlook
Essential Guidance
Learn More
Related Research
Synopsis
Figure: Emerging Translational Research IT Infrastructure Architectures
Figure: MD Anderson Core Translational Research IT Infrastructure Approach
Figure: Partners HealthCare Architecture for GIGPAD
Figure: Translational Research Collaboration Platforms in Use Today
|
